Role of Probiotics in Human Gut Microbiome-Associated Diseases
2
조회
0
다운로드
10
인용
0
참고문헌
키워드
초록
Probiotics, including bacteria and yeast, are live microorganisms that have demonstrated beneficial effects on human health. Recently, probiotic bacteria are constantly being studied and their applications are also being considered in promising adjuvant treatments for various intestinal diseases. Clinical trials and in vivo experiments have extended our current understanding of the important roles that probiotics play in human gut microbiomeassociated diseases. It has been documented through many clinical trials that probiotics could shape the intestinal microbiota leading to potential control of multiple bowel diseases and promotion of overall wellness. In this review, we focused on the relationship between probiotics and the human gut microbiota and its roles in gut microbiome-associated diseases. Here, we also discuss future directions and research areas that need further elucidation in order to better understand the roles of probiotics in the treatment of intestinal diseases.
Abstract
Probiotics, including bacteria and yeast, are live microorganisms that have demonstrated beneficial effects on human health. Recently, probiotic bacteria are constantly being studied and their applications are also being considered in promising adjuvant treatments for various intestinal diseases. Clinical trials and in vivo experiments have extended our current understanding of the important roles that probiotics play in human gut microbiomeassociated diseases. It has been documented through many clinical trials that probiotics could shape the intestinal microbiota leading to potential control of multiple bowel diseases and promotion of overall wellness. In this review, we focused on the relationship between probiotics and the human gut microbiota and its roles in gut microbiome-associated diseases. Here, we also discuss future directions and research areas that need further elucidation in order to better understand the roles of probiotics in the treatment of intestinal diseases.
참고문헌 (34)
- de Simone C, "The unregulated probiotic market", Clin. Gastroenterol. H, 17, pp.809~817 (2018)
- 최성미, "Difference in the Gut Microbiome between Ovariectomy-Induced Obesity and Diet-Induced Obesity", Journal of Microbiology and Biotechnology, 27(12), pp.2228~2236 (2017), 한국미생물·생명공학회
- Qin J, "A human gut microbial gene catalogue established by metagenomic sequencing", Nature, 464, pp.59~65 (2010)
- Wang W, "Semi-rational screening of the probiotics from the fecal flora of healthy adults against DSS-induced colitis mice by enhancing anti-inflammatory activity and modulating the gut microbiota", J. Microbiol. Biotechnol (2018)
- Sanders ME, "Health claims substantiation for probiotic and prebiotic products", Gut Microbes, 2, pp.127~133 (2011)
- Lorea Baroja M, "Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients", Clin. Exp. Immunol, 149, pp.470~479 (2007)
- Cremonini F, "Meta-analysis : the effect of probiotic administration on antibiotic-associated diarrhoea", Aliment. Pharmacol. Ther, 16, pp.1461~1467 (2002)
- 배준용, "Effects of Lactobacillus plantarum and Leuconostoc mesenteroides Probiotics on Human Seasonal and Avian Influenza Viruses", Journal of Microbiology and Biotechnology, 28(6), pp.893~901 (2018), 한국미생물·생명공학회
- Clemente JC, "The impact of the gut microbiota on human health : an integrative view", Cell, 148, pp.1258~1270 (2012)
- Ley RE, "Ecological and evolutionary forces shaping microbial diversity in the human intestine", Cell, 124, pp.837~848 (2006)
- Flint HJ, "Microbial degradation of complex carbohydrates in the gut", Gut Microbes, 3, pp.289~306 (2012)
- Apajalahti J, "Comparative gut microflora, metabolic challenges, and potential opportunities", J. Appl. Poultry Res, 14, pp.444~453 (2005)
- Hongyu Wen, "Comparative Analysis of Gut Microbial Communities in Children under 5 Years Old with Diarrhea", Journal of Microbiology and Biotechnology, 28(4), pp.652~662 (2018), 한국미생물·생명공학회
- Marteau P, "Probiotics and intestinal health effects : a clinical perspective", Br. J. Nutr, 88, pp.S51~S57 (2002)
- Hilty M, "Disordered microbial communities in asthmatic airways", PLoS One, 5(1), pp.e8578~ (2010)
- Carding S, "Dysbiosis of the gut microbiota in disease", Microb. Ecol. Health Dis, 26, pp.26191~ (2015)
- Ouwehand A, "Adhesion of probiotic micro-organisms to intestinal mucus", Int. Dairy J, 9, pp.623~630 (1999)
- Blaabjerg S, "Probiotics for the Prevention of Antibiotic-Associated Diarrhea in OutpatientsA Systematic Review and Meta-Analysis", Antibiotics, 6(4), pp.E21~ (2017)
- Conway S, "Does eating yogurt prevent antibiotic-associated diarrhoea? : A placebocontrolled randomised controlled trial in general practice", Br. J. Gen. Pract, 57, pp.953~959 (2007)
- Vanderhoof JA, "Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children", J. Pediatr, 135, pp.564~568 (1999)
- Bjarnason I, "A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn’s disease", Inflammopharmacology, 27, pp.465~473 (2019)
- Mahdi Shadnoush, "Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial", 대한소화기학회지, 65(4), pp.215~221 (2015), 대한소화기학회
- Yang J, "The association of diet, gut microbiota and colorectal cancer : what we eat may imply what we get", Protein Cell, 9, pp.474~487 (2018)
- Furrie E, "Synbiotic therapy(Bifidobacterium longum", Synergy 1)initiates resolution of inflammation in patients with active ulcerative colitis : a randomised controlled pilot trial, 2005, pp.54, 242~249
- Baumgart DC, "Inflammatory bowel disease : cause and immunobiology", Lancet, 369, pp.1627~1640 (2007)
- Cowan DC, "Effects of steroid therapy on inflammatory cell subtypes in asthma", Thorax, 65, pp.384~390 (2010)
- Fedorak RN, "The probiotic VSL#3 has antiinflammatory effects and could reduce endoscopic recurrence after surgery for Crohn’s disease", Clin. Gastroenterol. Hepatol, 13, pp.928~935 (2015)
- Center MM, "Worldwide variations in colorectal cancer", CA Cancer J. Clin, 59, pp.366~378 (2009)
- Triantafillidis JK, "Colorectal cancer and inflammatory bowel disease : epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies", Anticancer Res, 29, pp.2727~2737 (2009)
- Liong M-T, "Roles of probiotics and prebiotics in colon cancer prevention : postulated mechanisms and in-vivo evidence", Int. J. Mol. Sci, 9, pp.854~863 (2008)
- Krebs B, "Prebiotic and Synbiotic treatment before colorectal surgery-randomised double blind trial", Coll. Antropol, 40, pp.35~40 (2016)
- Boyle, R. J., "Probiotic use in clinical practice: what are the risks?", Am. J. Clin. Nutr, 83, pp.1256~1264 (2006)
- Beniwal RS, "A randomized trial of yogurt for prevention of antibiotic-associated diarrhea", Dig. Dis. Sci, 48, pp.2077~2082 (2003)
- Yang Y, "The effect of perioperative probiotics treatment for colorectal cancer : short-term outcomes of a randomized controlled trial", Oncotarget, 7, pp.8432~8440 (2016)